Saireito in Catheter Ablation for Atrial Fibrillation (SAIREITO study)
Completed
- Conditions
- Atrial fibrillation
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
First time ablation procedure for symptomatic atrial fibrillation
Patients who can be followed for 1-year after procedure
Patients from who we get written informed consent
Exclusion Criteria
Severe complications of ablation procedure
Patients who received ablation procedure or MAZE procedure for for atrial fibrillation before enrollment
Patients who already take Saireito
Chronic kidney disease (eGFR<30 or hemodialysis)
Chronic liver failure
Patients who can not take Saireito
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method Early recurrence 90 days atrial arrhythmia recurrence within 90 days after catheter ablation for atrial fibrillation
- Secondary Outcome Measures
Name Time Method